$6.490
-0.010 (-0.15%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACHV por análisis de gráficos similares
Alphio's ACHV stock price prediction model matches the current Achieve Life Sciences, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.50 (+0.23%). The 1-week path is $6.63 (+2.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Achieve Life Sciences, Inc.?
Achieve Life Sciences Inc (ACHV) appears to be a good buy right now, trading at $6.49 with a significant analyst price target of $18 from Stifel, indicating a potential upside of 177.4%. The company is advancing its cytisinicline drug for smoking cessation, which analysts believe has strong market potential. However, the stock has a low RSI of 29.212, indicating it is oversold, which could present a buying opportunity. The main risk is the company's negative earnings, with an EPS of -0.80 projected for the next quarter, which could affect short-term performance.
ACHV cerró en $6.49 el Friday, tras bajar -0.15%
Achieve Life Sciences, Inc. (ACHV) last closed at $6.49, losing -0.15%. These facts feed the 1-day and 1-week ACHV price prediction above.
Consenso de analistas
Achieve Life Sciences, Inc. (ACHV): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Achieve Life Sciences, Inc. (ACHV) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACHV, ordenadas por similitud.
Análisis de estacionalidad de ACHV
Historically the probability of a positive October return for ACHV is 80.95%. November offers the highest probability of a positive month at 97.44%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACHV
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $2.37 | $2.39 | $2.47 | -63.14% |
| Nov 2026 | $3.23 | $3.24 | $3.52 | -50.14% |
| Dec 2026 | $2.18 | $2.39 | $2.96 | -63.14% |
En 2026, se proyecta que Achieve Life Sciences, Inc. (ACHV) oscile entre $2.18 y $3.52.
Previsión mensual de Achieve Life Sciences, Inc. para 2026
En Oct de 2026, se proyecta que Achieve Life Sciences, Inc. promedie $2.39, con un mínimo de $2.37 y un máximo de $2.47.
En Nov de 2026, se proyecta que Achieve Life Sciences, Inc. promedie $3.24, con un mínimo de $3.23 y un máximo de $3.52.
En Dec de 2026, se proyecta que Achieve Life Sciences, Inc. promedie $2.39, con un mínimo de $2.18 y un máximo de $2.96.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.